Veracyte, Inc. (VCYT)
24.88
-0.16
(-0.64%)
USD |
NASDAQ |
Nov 20, 10:35
Veracyte Cash from Operations (Quarterly) : 40.26M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 40.26M |
| June 30, 2026 | 45.83M |
| March 31, 2026 | 35.22M |
| December 31, 2025 | 52.58M |
| September 30, 2025 | 44.76M |
| June 30, 2025 | 33.60M |
| March 31, 2025 | 5.362M |
| December 31, 2024 | 24.52M |
| September 30, 2024 | 29.96M |
| June 30, 2024 | 29.58M |
| March 31, 2024 | -8.966M |
| December 31, 2023 | 15.55M |
| September 30, 2023 | 14.17M |
| June 30, 2023 | 16.67M |
| March 31, 2023 | -2.172M |
| December 31, 2022 | 9.744M |
| September 30, 2022 | 7.026M |
| June 30, 2022 | -0.363M |
| March 31, 2022 | -8.872M |
| December 31, 2021 | 8.446M |
| September 30, 2021 | -1.393M |
| June 30, 2021 | 1.887M |
| March 31, 2021 | -40.56M |
| December 31, 2020 | 2.261M |
| September 30, 2020 | 1.752M |
| Date | Value |
|---|---|
| June 30, 2020 | -8.423M |
| March 31, 2020 | -5.301M |
| December 31, 2019 | 1.79M |
| September 30, 2019 | -1.556M |
| June 30, 2019 | -2.455M |
| March 31, 2019 | -1.011M |
| December 31, 2018 | -1.226M |
| September 30, 2018 | -1.783M |
| June 30, 2018 | -3.099M |
| March 31, 2018 | -7.413M |
| December 31, 2017 | -5.816M |
| September 30, 2017 | -5.103M |
| June 30, 2017 | -4.91M |
| March 31, 2017 | -8.086M |
| December 31, 2016 | -4.232M |
| September 30, 2016 | -7.438M |
| June 30, 2016 | -7.714M |
| March 31, 2016 | -8.598M |
| December 31, 2015 | -2.83M |
| September 30, 2015 | -3.802M |
| June 30, 2015 | -11.47M |
| March 31, 2015 | -8.867M |
| December 31, 2014 | -8.436M |
| September 30, 2014 | -6.532M |
| June 30, 2014 | -5.907M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Teleflex, Inc. | 147.76M |
| West Pharmaceutical Services, Inc. | 189.50M |
| Globus Medical, Inc. | 265.23M |
| Illumina, Inc. | 419.00M |
| Inspire Medical Systems, Inc. | 46.43M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -139.47M |
| Cash from Financing (Quarterly) | -0.479M |
| Free Cash Flow | 161.95M |
| Free Cash Flow Per Share (Quarterly) | 0.4581 |
| Free Cash Flow to Equity (Quarterly) | 37.30M |
| Free Cash Flow to Firm (Quarterly) | 37.92M |
| Free Cash Flow Yield | 8.07% |